Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The company’s OPPs could have nothing to do with the subject. How were the OPPS defined by the author at the time it was written?
The reality of the situation is IPIX is dead and shareholders are bagholders at a share price of 2 pennies and falling as the CEO‘a compensation remains unchanged. If it’s up to Leo, we’re all clearly screwed.
New shareholders, please grab a bag and join us in our misery.
Perhaps one day you will. For now, I don’t plan on elaborating.
Yep. Nothing more than transfer of wealth.
Cronies dumping shares at the bid.
Brilacidin is next.
Follow the money…..
Item 8.01 Other Events.
In a personal dispute between Dr. Krishna Menon and a party named Aruda, Aruda claimed that although he had participated in the invention relating to the compounds and therapeutic uses disclosed and claimed in US Patent No. 8,338,454 ("454" Patent") he was inadvertently omitted as an inventor from "454 Patent" and applications related thereto. On August 28, 2014, a settlement took place between Dr. Menon and Aruda which resulted in the following: Menon acquired all of the rights Aruda claimed in the Kevetrin patents in return for (i) the transfer to Aruda and designees an aggregate of 16,000,000 shares of stock in Cellceutix over a period of 16 months, currently owned by the Menon Trust and (ii) and assigned a portion of the royalty revenues that may be payable to Menon, to Aruda and designees, as further detailed in the Agreement titled "Amendment to Menon-Cellceutix Agreement Without Changing the Total Royalties Payable Under the Terms of the Prior Agreement". Menon then transferred all Kevetrin patent rights to Cellceutix. The aforementioned share transfer was strictly between the personal holdings of Mr. Krishna Menon, the Menon Trust, and Aruda. No shares or royalty payments were issued by the Company.
https://seekingalpha.com/filing/1717409
Speaking of assets, liabilities, and movement of cash,… Where did Kevetrin disappear to?
That makes sense.
The ABSSSI trial is one of many reminders that a company is only as good as the company it keeps. IPIX is dead.
Yup. Dead.
Two turds swirling the same bowl. At least we’re conserving water at that point.
.01 and change.
Good point! I’ll add the chart to the board intro when I have time.
One alternative that clearly didn’t work is B.
Neither here nor there. Kevetrin has been flushed, B is dead, the company is broke, the CEO is a slapdick, and the share price is well on its way to zero.
Yup, The run up was already in the mid $3’s prior to QIDP. The price dropped after that release. Brilacidin is cursed.
—————————
Recall the email from the CEO to shareholders announcing Kevetrin stabilized the growth of tumors.
The price run from the drug that recently disappeared from our portfolio overnight without any explanation to shareholders.
I can’t confirm that statement, but would suggest removing the words all from it unless the intention is to put the recipient in a defensive position to which I have none.
It appears the plan is to fund the CEO’s bank account at the expense of shareholders.
C’mon… After all the bullshit we’ve been through, the writing is on the wall. This turd is toast.
Ah, the good ole rat guide. What a crock of shit. The jig is up; IPIX is dead. We should be discussing things investors need to know about sub-penny trading.
https://www.clinicaltrialsarena.com/news/newscellceutix-begins-prurisols-phase-ii-trial-to-treat-plaque-psoriasis-4642182/
New investors, please join us in our misery.
A deal to shitcan Kevetrin?
Kevetrin gone in the blink of a filing - not one word to shareholders. Poof, 50% of the pipeline disappeared overnight.
Why would the CEO of a broke biotech company give 1/2 the company’s working capital to an unrelated international company, and at the same time shitcan 1 of only 2 drugs in his pipeline. Just out of the blue….?
Thanks.!
More posts than trades - IPIX is circling the toilet bowl.
Lipstick on a pig……
This turd is toast!
New investors, please join us in our misery by becoming a fellow bagholder.
Ding Ding Ding…. Winner winner chicken dinner….. 2’s are given and 3’s will be strong resistance.
The company is dead bud. Writing is on the wall.